Solara Active Pharma Sciences Limited (SOLARA.BO)
INR 727.75
(2.18%)
INR 727.75
(2.18%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 23.5 Billion INR | -18.91% |
| 2022 | 28.99 Billion INR | -1.81% |
| 2021 | 29.52 Billion INR | 12.97% |
| 2020 | 26.13 Billion INR | 21.36% |
| 2019 | 21.53 Billion INR | 9.87% |
| 2018 | 19.6 Billion INR | 7.6% |
| 2017 | 18.21 Billion INR | 18215230.0% |
| 2016 | 100 Thousand INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 22.89 Billion INR | 0.0% |
| 2024 Q1 | - INR | -100.0% |
| 2023 FY | 23.5 Billion INR | -18.91% |
| 2023 Q4 | 23.5 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 28.75 Billion INR | 0.0% |
| 2022 Q4 | 28.99 Billion INR | 0.0% |
| 2022 FY | 28.99 Billion INR | -1.81% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 28.66 Billion INR | 0.0% |
| 2021 FY | 29.52 Billion INR | 12.97% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 30.54 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 29.52 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 FY | 26.13 Billion INR | 21.36% |
| 2020 Q4 | 26.13 Billion INR | 0.0% |
| 2020 Q2 | 25.36 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 FY | 21.53 Billion INR | 9.87% |
| 2019 Q4 | 21.53 Billion INR | 24.11% |
| 2019 Q3 | 17.35 Billion INR | -16.63% |
| 2019 Q2 | 20.81 Billion INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 FY | 19.6 Billion INR | 7.6% |
| 2018 Q2 | 18.5 Billion INR | 0.0% |
| 2018 Q4 | 19.6 Billion INR | 0.0% |
| 2017 Q4 | 18.21 Billion INR | 9.31% |
| 2017 FY | 18.21 Billion INR | 18215230.0% |
| 2017 Q3 | 16.66 Billion INR | 0.0% |
| 2016 FY | 100 Thousand INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Ajanta Pharma Limited | 46.38 Billion INR | 49.315% |
| Amrutanjan Health Care Limited | 3.66 Billion INR | -540.814% |
| Sigachi Industries Limited | 6.94 Billion INR | -238.679% |
| Bal Pharma Limited | 3.2 Billion INR | -633.783% |
| Ind-Swift Laboratories Limited | 11.65 Billion INR | -101.781% |
| Medico Remedies Limited | 961.95 Million INR | -2343.945% |
| Lasa Supergenerics Limited | 1.5 Billion INR | -1458.282% |
| Venus Remedies Limited | 6.26 Billion INR | -275.055% |
| Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | -356.462% |
| Alpa Laboratories Limited | 1.82 Billion INR | -1187.339% |
| Nectar Lifesciences Limited | 21.91 Billion INR | -7.298% |
| Shilpa Medicare Limited | 30.93 Billion INR | 23.996% |
| Aarti Drugs Limited | 24.32 Billion INR | 3.347% |
| Lupin Limited | 239.97 Billion INR | 90.203% |
| Aurobindo Pharma Limited | 450.71 Billion INR | 94.784% |
| Zydus Lifesciences Limited | 292.8 Billion INR | 91.971% |
| Windlas Biotech Limited | 6.26 Billion INR | -275.429% |
| Suven Life Sciences Limited | 2.84 Billion INR | -725.18% |
| Eris Lifesciences Limited | 70.48 Billion INR | 66.648% |
| Valiant Laboratories Limited | 3.42 Billion INR | -586.037% |
| J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | 41.14% |
| Ipca Laboratories Limited | 111.01 Billion INR | 78.823% |
| Bliss GVS Pharma Limited | 12.13 Billion INR | -93.675% |
| Achyut Healthcare Limited | 309.52 Million INR | -7495.454% |
| Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 97.249% |
| Bajaj HealthCare Limited | 7.65 Billion INR | -207.264% |
| RPG Life Sciences Limited | 5.12 Billion INR | -358.393% |
| Mankind Pharma Limited | 119.63 Billion INR | 80.348% |
| Laurus Labs Limited | 83.87 Billion INR | 71.969% |
| Piramal Pharma Limited | 153.11 Billion INR | 84.646% |
| Syncom Formulations (India) Limited | 4.04 Billion INR | -480.966% |
| Torrent Pharmaceuticals Limited | 150.61 Billion INR | 84.39% |
| Alembic Pharmaceuticals Limited | 64.45 Billion INR | 63.526% |
| Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 83.627% |
| Unichem Laboratories Limited | 31.69 Billion INR | 25.822% |
| Sequent Scientific Limited | 15.4 Billion INR | -52.622% |
| Novartis India Limited | 9.24 Billion INR | -154.177% |
| Wanbury Limited | 3.43 Billion INR | -584.427% |
| Suven Pharmaceuticals Limited | 22.54 Billion INR | -4.298% |
| Wockhardt Limited | 76.49 Billion INR | 69.264% |
| Themis Medicare Limited | 5.66 Billion INR | -315.059% |
| Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -983.002% |
| Jubilant Pharmova Limited | 115.48 Billion INR | 79.643% |
| Glenmark Life Sciences Limited | 28.5 Billion INR | 17.522% |
| Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 93.933% |
| Divi's Laboratories Limited | 154.7 Billion INR | 84.803% |
| NATCO Pharma Limited | 69.06 Billion INR | 65.959% |
| Gufic Biosciences Limited | 10.92 Billion INR | -115.183% |
| IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | -4.748% |
| Ind-Swift Limited | 6.54 Billion INR | -259.215% |
| Procter & Gamble Health Limited | 7.94 Billion INR | -195.956% |
| FDC Limited | 24.68 Billion INR | 4.746% |
| Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -1219.469% |
| Granules India Limited | 55.2 Billion INR | 57.418% |
| Medicamen Biotech Limited | 2.94 Billion INR | -698.228% |
| Alkem Laboratories Limited | 155.74 Billion INR | 84.905% |
| AstraZeneca Pharma India Limited | 10.78 Billion INR | -118.08% |
| Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -4893.257% |
| Brooks Laboratories Limited | 904.45 Million INR | -2499.314% |
| Megasoft Limited | 3.65 Billion INR | -542.515% |
| ZIM Laboratories Limited | 4.46 Billion INR | -426.151% |
| Strides Pharma Science Limited | 58.39 Billion INR | 59.742% |
| Neuland Laboratories Limited | 18.32 Billion INR | -28.288% |
| Morepen Laboratories Limited | 12.93 Billion INR | -81.793% |
| Hikal Limited | 24.87 Billion INR | 5.475% |
| Indoco Remedies Limited | 21.44 Billion INR | -9.616% |
| Aarti Pharmalabs Limited | 25.82 Billion INR | 8.952% |
| Kilitch Drugs (India) Limited | 2.4 Billion INR | -879.315% |
| Mangalam Drugs & Organics Limited | 3.33 Billion INR | -605.096% |
| Hester Biosciences Limited | 6.62 Billion INR | -254.944% |